PET-CT en pacientes con tumores de cabeza y cuello

Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108.

https://doi.org/10.3322/canjclin.55.2.74

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96.

https://doi.org/10.3322/CA.2007.0010

Colombia, Departamento Administrativo Nacional de Estadística. Estadísticas vitales-Defunciones no fetales. [Internet] Bogotá: DANE; 2006 [citado 20 enero 2010]. Disponible en: http://www.dane.gov.co/files/investigaciones/poblacion/defunciones/defun_2007/CUADRO5.xls.

Colombia, Instituto Nacional de Cancerología. Registro Institucional de Cáncer. En: Anuario Estadístico 2007. Bogotá: INC; 2007: 11-13.

Agarwal V, Branstetter BF 4th, Johnson JT. Indications for PET/CT in the head and neck. Otolaryngol Clin North Am. 2008;41(1):23-50.

https://doi.org/10.1016/j.otc.2007.10.005

Branstetter BF 4th, Blodgett TM, Zimmer LA, Snyderman CH, Johnson JT, Raman S, et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology. 2005;235(2):580-6.

https://doi.org/10.1148/radiol.2352040134

Dong MJ, Zhao K, Lin XT, Zhao J, Ruan LX, Liu ZF. Role of fluorodexyglucose-PET versus flurodeoxyglucose-PET/computed tomography in detection of unknown primary tumor: a meta-analysis of the literature. Nucl Med Commun. 2008;29(9):791-802.

Liu T, Xu W, Yan WL, Ye M, Bai YR, Huang G. FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review. Radiother Oncol. 2007;85(3):327-35.

https://doi.org/10.1016/j.radonc.2007.11.002

Poland, Agency for Health Technology Assessment in Poland. Cost-effectiveness analysis of PET-CT positron emission tomography and the diagnostic technologies financed from public sources in oncological diagnostic in Poland. Clinical and epidemiological aspects. Warszawa-Nowy Sacz, Agency for Health Technology Assessment in Poland; 2006.

Facey K, Bradbury I, Laking G, Payne E. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Health Technol Assess. 2007;11(44):iii-iv, xi-267.

https://doi.org/10.3310/hta11440

Quon A, Fischbein NJ, McDougall IR, Le QT, Loo BW Jr, Pinto H, et al. Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma. J Nucl Med. 2007;48 Suppl 1:58S-67S.

Fleming AJ Jr, Johansen ME. The clinician's expectations from the use of positron emission tomography/computed tomography scanning in untreated and treated head and neck cancer patients. Curr Opin Otolaryngol Head Neck Surg. 2008;16(2):127-34.

https://doi.org/10.1097/MOO.0b013e3282f4939a

O'Meara WP, Lee N. Advances in nasopharyngeal carcinoma. Curr Opin Oncol. 2005;17(3):225-30. Review.

https://doi.org/10.1097/01.cco.0000156197.29872.8e

Kowalski LP, Sanabria A. Elective neck dissection in oral carcinoma: a critical review of the evidence. Acta Otorhinolaryngol Ital. 2007;27(3):113-7. Review.

García C, Flamen P. Role of positron emission tomography in the management of head and neck cancer in the molecular therapy era. Curr Opin Oncol. 2008;20(3):275-9.

https://doi.org/10.1097/CCO.0b013e3282faa0cb

Goerres GW, Schmid DT, Grätz KW, von Schulthess GK, Eyrick GK. Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity. Oral Oncol. 2003;39(6):547-51.

https://doi.org/10.1016/S1368-8375(03)00016-2

Wild D, Eyrich GK, Ciernik IF, Stoeckli SJ, Schuknecht B, Goerres GW. In-line (18)F-fluorodeoxyglucose positron emission tomography with computed tomography (PET/CT) in patients with carcinoma of the sinus/nasal area and orbit. J Craniomaxillofac Surg. 2006;34(1):9-16.

https://doi.org/10.1016/j.jcms.2005.08.001

Koshy M, Paulino AC, Howell R, Schuster D, Halkar R, Davis LW. F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer. Head Neck. 2005;27(6):494-502.

https://doi.org/10.1002/hed.20179

Freudenberg LS, Fischer M, Antoch G, Jentzen W, Gutzeit A, Rosenbaum SJ, et al. Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary. Med Princ Pract. 2005;14(3):155-60.

https://doi.org/10.1159/000084632

Zimmer LA, Snyderman C, Fukui MB, Blodgett T, McCook B, Townsend DW, et al. The use of combined PET/CT for localizing recurrent head and neck cancer: the Pittsburgh experience. Ear Nose Throat J. 2005;84(2):104, 106, 108-10.

https://doi.org/10.1177/014556130508400215

Rödel R, Straehler-Pohl HJ, Palmedo H, Reichmann K, Jaeger U, Reinhardt MJ, et al. [PET/CT imaging in head and neck tumors]. Radiologe. 2004.;44(11):1055-9. German.Ç

https://doi.org/10.1007/s00117-004-1125-6

Schöder H, Yeung HW, Gonen M, Kraus D, Larson SM. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology. 2004;231(1):65-72.

https://doi.org/10.1148/radiol.2311030271

Zanation AM, Sutton DK, Couch ME, Weissler MC, Shockley WW, Shores CG. Use, accuracy, and implications for patient management of [18F]-2-fluorodeoxyglucose-positron emission/computerized tomography for head and neck tumors. Laryngoscope. 2005;115(7):1186-90.

https://doi.org/10.1097/01.MLG.0000163763.89647.9F

Ciernik IF, Dizendorf E, Baumert BG, Reiner B, Burger C, Davis JB, et al. Radiation treatment planning with an integrated positron emission and computed tomography (PET/CT): a feasibility study. Int J Radiat Oncol Biol Phys. 2003;57(3):853-63.

https://doi.org/10.1016/S0360-3016(03)00346-8

Koshy M, Howell R, Schuster D, Davis LW. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2005;61(5):1385-92.

https://doi.org/10.1016/j.ijrobp.2004.08.037